Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes?

Diabetic MedicineEarly View e15185 LETTER Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes? Soon H. Song, Corresponding Author Soon H. Song [email protected] orcid.org/0000-0001-5316-1797 Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK Correspondence Soon H. Song, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Email: [email protected]Search for more papers by this authorBrian M. Frier, Brian M. Frier The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKSearch for more papers by this author Soon H. Song, Corresponding Author Soon H. Song [email protected] orcid.org/0000-0001-5316-1797 Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK Correspondence Soon H. Song, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Email: [email protected]Search for more papers by this authorBrian M. Frier, Brian M. Frier The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKSearch for more papers by this author First published: 20 July 2023 https://doi.org/10.1111/dme.15185Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Ólafsdóttir AF, Polonsky W, Bolinder J, et al. A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther. 2018; 20: 274-284. 2Graveling AJ, Frier BM. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 2010; 36: S64-S74. 3Ali N, El Hamdaoui S, Schouwenberg BJ, et al. Fall in prevalence of impaired awareness of hypoglycaemia in individuals with type 1 diabetes. Diabet Med. 2023; 40:e15042. 4Olsen SE, Asvold BO, Frier BM, et al. Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with type 1 diabetes: the association with diabetes duration. Diabet Med. 2014; 31: 1210-1217. 5Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycaemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013; 36: 4160-4416. 6Van Beers CAJ, DeVries JH, Kleiger SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016; 4: 893-902. 7Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018; 391: 1367-1377. 8Lin YK, Hung M, Sharma A, et al. Impaired awareness of hypoglycemia continues to be a risk factor for severe hypoglycemia despite the use of continuous glucose monitoring system in type 1 diabetes. Endocr Pract. 2019; 25: 517-525. 9Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2008; 25: 501-504. Early ViewOnline Version of Record before inclusion in an issuee15185 ReferencesRelatedInformation